- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有243家主力机构披露2026-06-30报告期持股数据，持仓量总计1.89亿股，占流通A股45.42%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了93%的股票
技术面评分前10的股票
近期的平均成本为44.00元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为44.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"44.00","date":1791446792,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.10.09","stock":"3.91","trade":"0.82","ind":"0.17"},{"date":"2026.10.08","stock":"-4.58","trade":"-3.10","ind":"-2.07"},{"date":"2026.09.30","stock":"3.85","trade":"3.11","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.99","trade":"-0.15","ind":"0.34"},{"date":"2026.09.28","stock":"-1.15","trade":"-1.56","ind":"-3.44"},{"date":"2026.09.24","stock":"2.50","trade":"-2.13","ind":"-2.34"},{"date":"2026.09.23","stock":"0.48","trade":"0.90","ind":"-0.64"},{"date":"2026.09.22","stock":"3.37","trade":"0.79","ind":"-0.05"},{"date":"2026.09.21","stock":"6.75","trade":"5.10","ind":"0.65"},{"date":"2026.09.18","stock":"6.41","trade":"2.54","ind":"1.72"},{"date":"2026.09.17","stock":"1.11","trade":"1.45","ind":"-0.33"},{"date":"2026.09.16","stock":"1.49","trade":"2.42","ind":"1.26"},{"date":"2026.09.15","stock":"-0.98","trade":"-1.54","ind":"-0.72"},{"date":"2026.09.14","stock":"2.37","trade":"3.99","ind":"-0.64"},{"date":"2026.09.11","stock":"-1.24","trade":"-2.77","ind":"-1.08"},{"date":"2026.09.10","stock":"-1.38","trade":"-2.42","ind":"-0.77"},{"date":"2026.09.09","stock":"-1.26","trade":"-0.75","ind":"0.15"},{"date":"2026.09.08","stock":"1.14","trade":"3.08","ind":"-0.52"},{"date":"2026.09.07","stock":"0.05","trade":"0.78","ind":"1.91"},{"date":"2026.09.04","stock":"-1.65","trade":"-0.66","ind":"-0.79"},{"date":"2026.09.03","stock":"-0.85","trade":"-0.62","ind":"0.10"}]
华大基因,深证成指,医疗服务指数
压力支撑
该股压力位为43.74元，支撑位为41.73元。
[{"text":"\u538b\u529b\u4f4d","value":"43.74","date":1791475200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"41.73","date":1791475200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了80%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月09日 20:31
| 机构今日流向(万元) | -665.07 | 机构5日流向(万元) | -2640.30 |
| 机构10日流向(万元) | -4955.40 | 机构20日流向(万元) | -3876.88 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1114.58万股，其中基金净减仓26家，主力净增仓4家，暂未发现中长期投资价值。
截止2026-06-30，共243家主力机构（基金238家，一般法人5家），持仓量总计18895.94万股，占流通A股45.42%
其中，基金持仓与2025-12-31相比：
增仓：60家 ，增持 330.52万股
减仓：86家 ，减持 561.13万股
新出现在主力名单中：77家 ，持有338.12万股
从主力名单中消失：73家 ，原持有1306.63万股
其中，基金持仓与2025-12-31相比：
增仓：60家 ，增持 330.52万股
减仓：86家 ，减持 561.13万股
新出现在主力名单中：77家 ，持有338.12万股
从主力名单中消失：73家 ，原持有1306.63万股
消息面诊股
诊断结果：5.5消息面打败了34%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华大基因：10月8日获融资买入5020.27万元
2026-10-09 - 市场科技题材高歌猛进，现有30支科技细分领域龙头股
2026-10-08 - 华夏磐益一年定开混合重仓股华大基因跌4.58%
2026-10-08 - 华大基因：9月30日获融资买入4738.53万元
2026-10-08 - AI4S智变，生命科学启新论坛回顾
2026-09-30 - 肠道菌群“跷跷板”拓扑结构揭示结直肠肿瘤潜在机制！
2026-09-30 - 华大基因：9月29日获融资买入2729.75万元
2026-09-30 - 华大基因：9月28日获融资买入5539.11万元
2026-09-29 - 华大基因：9月24日获融资买入8319.70万元
2026-09-28 - 华大基因墨西哥战略合作伙伴Géntodos实验室启
2026-09-24
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-12 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-29 |
| 一般消息 | 高管变动 | 因即将达到法定退休年龄 | 2026-05-07 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-03 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-01-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-28 |
| 一般消息 | 高管变动 | 工作安排 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-03 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：4.3行业面打败了62%的股票
医疗服务行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.10.09","price":"0.17","value":"0.82"},{"date":"2026.10.08","price":"-2.07","value":"-3.10"},{"date":"2026.09.30","price":"-0.11","value":"3.11"},{"date":"2026.09.29","price":"0.34","value":"-0.15"},{"date":"2026.09.28","price":"-3.44","value":"-1.56"},{"date":"2026.09.24","price":"-2.34","value":"-2.13"},{"date":"2026.09.23","price":"-0.64","value":"0.90"},{"date":"2026.09.22","price":"-0.05","value":"0.79"},{"date":"2026.09.21","price":"0.65","value":"5.10"},{"date":"2026.09.18","price":"1.72","value":"2.54"},{"date":"2026.09.17","price":"-0.33","value":"1.45"},{"date":"2026.09.16","price":"1.26","value":"2.42"},{"date":"2026.09.15","price":"-0.72","value":"-1.54"},{"date":"2026.09.14","price":"-0.64","value":"3.99"},{"date":"2026.09.11","price":"-1.08","value":"-2.77"},{"date":"2026.09.10","price":"-0.77","value":"-2.42"},{"date":"2026.09.09","price":"0.15","value":"-0.75"},{"date":"2026.09.08","price":"-0.52","value":"3.08"},{"date":"2026.09.07","price":"1.91","value":"0.78"},{"date":"2026.09.04","price":"-0.79","value":"-0.66"},{"date":"2026.09.03","price":"0.10","value":"-0.62"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 诺禾致源 | 53.79% | 6.52% | 5.3分 |
| 2 | 南模生物 | 52.67% | 16.88% | 5.8分 |
| 3 | 南华生物 | 45.20% | -14.13% | 6.3分 |
| 4 | 澳洋健康 | 33.11% | 9.04% | 6.0分 |
| 5 | 和元生物 | 30.59% | 0.70% | 5.5分 |
| 6 | 贝瑞基因 | 28.26% | 2.63% | 6.1分 |
| 8 | 奥浦迈 | 27.84% | -7.68% | 6.2分 |
| 10 | 博腾股份 | 23.14% | -0.63% | 5.3分 |
| 12 | 万邦医药 | 21.85% | -6.55% | 4.9分 |
| 14 | 昭衍新药 | 17.94% | 13.39% | 6.6分 |
| 16 | 诺思格 | 17.58% | -3.44% | 5.4分 |
| 18 | 迪安诊断 | 15.12% | -1.88% | 6.8分 |
| 20 | 兰卫医学 | 11.76% | -0.67% | 5.9分 |
| 22 | 美迪西 | 9.66% | -3.62% | 6.3分 |
| 24 | 泰格医药 | 9.03% | -2.87% | 5.7分 |
| 26 | 九洲药业 | 8.08% | 0.43% | 5.9分 |
| 28 | 普蕊斯 | 6.81% | -1.23% | 5.8分 |
| 30 | 海特生物 | 6.44% | 5.05% | 4.9分 |
| 32 | 凯莱英 | 5.77% | -0.21% | 5.6分 |
| 34 | 百诚医药 | 5.23% | -5.35% | 4.2分 |
| 36 | 光正眼科 | 3.48% | 3.23% | 6.0分 |
| 38 | 皓元医药 | 1.42% | -10.03% | 4.7分 |
| 40 | 华厦眼科 | 1.27% | 1.68% | 6.1分 |
| 42 | 新里程 | 0.48% | 2.43% | 5.9分 |
| 44 | 大东方 | -0.25% | 4.74% | 5.8分 |
| 46 | 皓宸医疗 | -3.82% | -7.35% | 5.6分 |
| 48 | 大湖股份 | -4.17% | 0.55% | 5.8分 |
| 50 | 阳光诺和 | -4.97% | -7.84% | 4.2分 |
| 52 | 三博脑科 | -7.59% | -3.02% | 5.5分 |
| 54 | 创新医疗 | -9.74% | -5.04% | 5.0分 |
| 56 | 华康洁净 | -17.76% | -15.80% | 4.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/102 ， 20/102。
[{"date":"2026-06-30","value":"0.56","vol":"2.39"},{"date":"2026-03-31","value":"-0.11","vol":"0.96"},{"date":"2025-12-31","value":"-7.00","vol":"2.21"},{"date":"2025-09-30","value":"-0.23","vol":"3.24"},{"date":"2025-06-30","value":"0.06","vol":"2.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.56 | -0.11 | -7.00 | -0.23 | 0.06 |
| 行业(%) | 2.39 | 0.96 | 2.21 | 3.24 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"41.52","vol":"34.37"},{"date":"2026-03-31","value":"39.71","vol":"34.16"},{"date":"2025-12-31","value":"37.59","vol":"34.36"},{"date":"2025-09-30","value":"42.97","vol":"36.06"},{"date":"2025-06-30","value":"44.65","vol":"36.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
41.52 | 39.71 | 37.59 | 42.97 | 44.65 |
| 行业(%) | 34.37 | 34.16 | 34.36 | 36.06 | 36.21 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/102 ， 6/102。
[{"date":"2026-06-30","value":"9.59","vol":"16.81"},{"date":"2026-03-31","value":"20.35","vol":"16.75"},{"date":"2025-12-31","value":"-4.18","vol":"8.22"},{"date":"2025-09-30","value":"-5.39","vol":"3.06"},{"date":"2025-06-30","value":"-12.82","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
9.59 | 20.35 | -4.18 | -5.39 | -12.82 |
| 行业(%) | 16.81 | 16.75 | 8.22 | 3.06 | 2.87 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"718.24","vol":"134.87"},{"date":"2026-03-31","value":"81.93","vol":"79.49"},{"date":"2025-12-31","value":"31.69","vol":"23.26"},{"date":"2025-09-30","value":"82.78","vol":"20.05"},{"date":"2025-06-30","value":"-68.25","vol":"-63.31"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
718.24 | 81.93 | 31.69 | 82.78 | -68.25 |
| 行业(%) | 134.87 | 79.49 | 23.26 | 20.05 | -63.31 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/102 ， 31/102。
[{"date":"2026-06-30","value":"0.16","vol":"0.22"},{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.31","vol":"0.44"},{"date":"2025-09-30","value":"0.22","vol":"0.32"},{"date":"2025-06-30","value":"0.13","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.07 | 0.31 | 0.22 | 0.13 |
| 行业(次) | 0.22 | 0.10 | 0.44 | 0.32 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.14","vol":"7.15"},{"date":"2026-03-31","value":"1.03","vol":"3.44"},{"date":"2025-12-31","value":"4.28","vol":"15.84"},{"date":"2025-09-30","value":"2.72","vol":"10.95"},{"date":"2025-06-30","value":"1.55","vol":"7.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.14 | 1.03 | 4.28 | 2.72 | 1.55 |
| 行业(次) | 7.15 | 3.44 | 15.84 | 10.95 | 7.15 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 52/102 ， 38/102。
[{"date":"2026-06-30","value":"-9.74","vol":"15.88"},{"date":"2026-03-31","value":"-22.43","vol":"0.86"},{"date":"2025-12-31","value":"36.20","vol":"20.95"},{"date":"2025-09-30","value":"-2.19","vol":"16.52"},{"date":"2025-06-30","value":"-1.75","vol":"16.38"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -9.74 | -22.43 | 36.20 | -2.19 | -1.75 |
| 行业 | 15.88 | 0.86 | 20.95 | 16.52 | 16.38 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.96","vol":"0.94"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.97","vol":"0.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.96 | - | 0.89 | - | 0.97 |
| 行业 | 0.94 | 0.00 | 0.89 | 0.01 | 0.91 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/102 ， 38/102。
[{"date":"2026-06-30","value":"2.81","vol":"3.00"},{"date":"2026-03-31","value":"2.60","vol":"3.37"},{"date":"2025-12-31","value":"2.42","vol":"3.64"},{"date":"2025-09-30","value":"2.81","vol":"3.67"},{"date":"2025-06-30","value":"2.81","vol":"3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.81 | 2.60 | 2.42 | 2.81 | 2.81 |
| 行业 | 3.00 | 3.37 | 3.64 | 3.67 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.50","vol":"2.40"},{"date":"2026-03-31","value":"2.31","vol":"2.78"},{"date":"2025-12-31","value":"2.18","vol":"3.00"},{"date":"2025-09-30","value":"2.49","vol":"2.94"},{"date":"2025-06-30","value":"2.49","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.50 | 2.31 | 2.18 | 2.49 | 2.49 |
| 行业 | 2.40 | 2.78 | 3.00 | 2.94 | 2.87 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/102 ， 36/102。
[{"date":"2026-06-30","value":"23.11","vol":"33.06"},{"date":"2026-03-31","value":"24.73","vol":"32.97"},{"date":"2025-12-31","value":"26.74","vol":"32.98"},{"date":"2025-09-30","value":"23.82","vol":"32.60"},{"date":"2025-06-30","value":"24.81","vol":"33.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.11 | 24.73 | 26.74 | 23.82 | 24.81 |
| 行业(%) | 33.06 | 32.97 | 32.98 | 32.60 | 33.58 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.30","vol":"0.90"},{"date":"2026-03-31","value":"0.33","vol":"0.97"},{"date":"2025-12-31","value":"0.37","vol":"0.97"},{"date":"2025-09-30","value":"0.32","vol":"0.92"},{"date":"2025-06-30","value":"0.33","vol":"0.96"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.30 | 0.33 | 0.37 | 0.32 | 0.33 |
| 行业(%) | 0.90 | 0.97 | 0.97 | 0.92 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-6.17","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"1.13","blueLineValue":"0.27","type":"YC"}]